Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
This syndrome is characterized by the association of Moebius syndrome (congenital facial palsy with impaired ocular abduction) with peripheral axonal neuropathy and hypogonadotropic hypogonadism.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome.
1 publication has been identified in PubMed for Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome. Research spans Review / Meta-Analysis (100%).
Molinari S (2025). [PMID: 39846147](https://pubmed.ncbi.nlm.nih.gov/39846147/). *J Pediatr Endocrinol Metab*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 2:39 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome